Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 260

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection

Biswas, Robin, Tabor, Edward, Hsia, Chu Chieh, Wright, David J., Laycock, Megan E., Fiebig, Eberhard W., Peddada, Lorraine, Smith, Richard, Schreiber, George B., Epstein, Jay S., Nemo, George J., Busch, Michael P. · 2003 · Transfusion

Abstract

BACKGROUND: A study was designed to estimate relative analytic sensitivity and window‐period (WP) closure and to project incremental yield of newer HBsAg tests, pooled‐sample NAT, and single‐sample NAT, compared to currently licensed HBsAg tests. STUDY DESIGN AND METHODS: HBV DNA and HBsAg test results for 23 HBV seroconversion (SC) panels were first analyzed to construct a model of primary HBV viremia. One‐hundred representative samples were then selected from 10 panels and coded with 28 analytical controls. All 128 samples were tested by seven HBsAg tests and by four pooled‐sample and three single‐sample NAT assay formats. Results were analyzed to obtain differential times to HBV detection and combined with HBV incidence rates to project comparative yields. RESULTS: HBV doubling time during the ramp‐up phase was estimated at 2.56 days. HBsAg concentrations at cutoff for new tests ranged from 0.07 to 0.12 ng per mL, compared with 0.13 to 0.62 ng per mL for licensed tests. Estimated viral load at cutoff ranged from 102 to 267 IU per mL for new tests and from 363 to 1069 IU per mL for licensed tests. HBsAg tests detected 31 to 63 percent of early ramp‐up phase samples in the 100‐member seroconversion panel study, while pooled‐sample NAT detected 55 to 71 percent and single‐sample NAT, 82 to 99 percent. Compared with currently licensed HBsAg assays, newer HBsAg assays would reduce the WP by 2 to 9 days; pooled‐sample NAT would reduce the WP by 9 to 11 days; and single‐sample NAT would reduce the WP by 25 to 36 days. CONCLUSION: Newer HBsAg tests would be expected to detect an additional 15 to 21 infected units per 10 7 donations, compared to licensed HBsAg tests. Sensitivity, WP closure, and yield projections for newer HBsAg assays and pooled‐sample NAT are comparable. Single‐sample NAT would increase yield by 13 to 15 units per 10 7 donations over pooled‐sample NAT and newer HBsAg assays and by 35 to 50 units per 10 7 donations over currently licensed HBsAg assays.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1537-2995.2003.00424.x

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 260

Metadata

Authors
Biswas, R., Tabor, E., Hsia, C. C., Wright, D. J., Laycock, M. E., Fiebig, E. W., Peddada, L., Smith, R., Schreiber, G. B., Epstein, J. S., Nemo, G. J., & Busch, M. P.
Venue
Transfusion
Publisher
Wiley
Published
2003-05-21
Volume
43
Issue
6
Pages
788-798
ISSN
  • 0041-1132 (ISSN-L)
  • 1537-2995
OpenAlex
W2143130283
Cited by
260
References
6
FWCI
13.90
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection. https://app.cochat.ai/papers/10.1046/j.1537-2995.2003.00424.x
The paper
Biswas, R., Tabor, E., Hsia, C. C., Wright, D. J., Laycock, M. E., Fiebig, E. W., Peddada, L., Smith, R., Schreiber, G. B., Epstein, J. S., Nemo, G. J., & Busch, M. P. (2003). Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection. Transfusion. https://doi.org/10.1046/j.1537-2995.2003.00424.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.